Portuguese 
English 
Spanish 
6 min of reading 
0 comments 
Accelerated destruction of red blood cells, platelet dysfunction in microgravity, and mutations in blood stem cells: three recent discoveries show that the bodies of astronauts react to space in ways that medicine still does not know how to solve, raising concrete questions about the viability of long-duration crewed missions to Mars.
The blood of astronauts is failing in space in ways that science did not anticipate. Three recent discoveries reveal a complete hematological syndrome affecting those living in microgravity: red blood cells are destroyed faster than the body can replace them, platelets lose their ability to function properly, and the stem cells responsible for producing new blood begin to accumulate mutations. The result is an organism that coagulates too much when it shouldn’t and too little when the situation demands, with two opposing conditions happening simultaneously, without clear pharmacological treatment.
The problem is not theoretical. This year, Colonel Mike Fincke was involved in the first medical evacuation from the International Space Station (ISS), demonstrating that the health risks to astronauts in space are concrete and immediate. With plans for crewed missions to Mars that could last for years, these discoveries raise an uncomfortable question: our bodies simply were not made to live outside Earth, and insisting without being prepared could cost lives. Blood is just the most recent and perhaps the most alarming reminder.
The red blood cells of astronauts are being destroyed in space
The first of the three discoveries is about space anemia. In space, the bodies of astronauts destroy red blood cells at an accelerated rate faster than they can produce new ones. This imbalance creates a persistent anemia that does not resolve during the mission and can take up to a year after returning to Earth for blood levels to return to normal.
-
A startup sends robotic gloves for users to wear at home while washing dishes, folding clothes, and making coffee; every finger movement is recorded and sent back to train a domestic robot that has already learned 10 million real tasks without ever having entered a kitchen.
-
In a flooded well, archaeologists found a 1,700-year-old Roman egg that still contains clear and yolk intact inside the very thin shell.
-
Something is happening around the Earth: Inside the huge explosion of fireballs in 2026
-
A hot air bubble coming from Argentina expands over Brazil, causing thermometers to exceed 38 degrees with a thermal sensation of 40 degrees in late March, affecting 6 states at once.
The mechanism is a direct consequence of microgravity. On Earth, gravity helps distribute blood evenly throughout the body. In space, without that gravitational pull, blood redistributes to the upper part of the organism.
The body interprets this accumulation as excess and begins to destroy red blood cells to compensate but the result is a real deficiency that compromises the ability to transport oxygen.
For astronauts on short missions on the ISS, anemia is manageable. For a trip to Mars lasting two to three years, the scenario changes completely.
Astronauts operating with chronic anemia in a hostile environment, without access to transfusions or hospital treatment, represent an operational risk that no space agency can ignore.
Platelets fail in microgravity and no one knows how to fix it
The second discovery is about platelet dysfunction. Platelets are the cells responsible for blood clotting when you get a cut; they form the plug that stops the bleeding.
In space, microgravity alters the behavior of these cells in a paradoxical way: the blood of astronauts becomes simultaneously more prone to thrombosis and slower to clot when necessary.
This means that an astronaut in microgravity is at increased risk of forming dangerous internal clots such as deep vein thrombosis and, at the same time, may have difficulty stopping bleeding in the event of injury or surgical procedure.
These are two opposing conditions coexisting in the same organism, and there is no pharmacological approach that treats both simultaneously. Anticoagulants solve one problem and worsen the other.
The platelet paradox is particularly concerning because space medicine still has no solution for it. On the ISS, astronauts are just a few hours away from a terrestrial hospital in case of emergency.
On a mission to Mars, this option does not exist. Any hemorrhagic or thrombotic event would have to be treated on board, with limited resources and no possibility of evacuation.
Mutations in blood: the stem cells of astronauts are changing
The third discovery is perhaps the most unsettling. Researchers have identified that the hematopoietic stem cells responsible for producing all blood cells accumulate somatic mutations when exposed to the space environment. These mutations are not genetically inherited but acquired during the time spent in space, and can permanently alter how the body produces blood.
The type of mutation observed in astronauts is similar to what occurs naturally with aging on Earth, but at an accelerated rate. In practice, space ages the blood system faster than life on the Earth’s surface. The long-term implications are still being studied, but include an increased risk of hematological diseases, including certain types of blood cancer.
For long-duration missions, mutations in the blood of astronauts represent a cumulative risk. The longer they are in space, the more mutations accumulate. A round trip to Mars that could last between two and three years would expose astronauts to an unprecedented period of mutation accumulation in the history of space exploration. And, unlike anemia or platelet dysfunction, genetic mutations do not simply reverse upon returning to Earth.
The first medical evacuation from the ISS and what it reveals about the future
The evacuation of Colonel Mike Fincke from the International Space Station this year was a milestone that many preferred to downplay, but it says a lot about the current state of space medicine. It was the first time an astronaut needed to be removed from the ISS for medical reasons, and all indications are that it will not be the last as more people spend more time in microgravity.
The event exposed an uncomfortable reality: the medical infrastructure in space is rudimentary. The ISS has basic diagnostic equipment and an emergency kit, but lacks the capacity for complex surgeries, transfusions, or treatment of severe hematological conditions.
If an astronaut develops deep vein thrombosis or an internal hemorrhage on the station, treatment options are extremely limited.
With the multiplication of crewed flights including commercial missions from SpaceX and space tourism programs, the number of people exposed to microgravity will grow rapidly.
The evacuation of Fincke is a warning: space medicine needs to evolve at the same speed as rocket engineering, or human exploration of space will produce avoidable tragedies.
What these discoveries mean for Mars colonization plans
All three discoveries converge to an uncomfortable conclusion: long-duration crewed missions, such as a trip to Mars, expose astronauts to hematological risks that still have no medical solution.
Chronic anemia, coagulation dysfunction, and cumulative mutations in the blood form a syndrome that microgravity imposes on the human body without asking for permission.
The temptation is to downplay these problems and trust that technology will solve everything in time. But the researchers themselves warn of the risk of the so-called “Gelsinger effect,” a reference to the case of Jesse Gelsinger, whose death in a clinical trial of gene therapy in 1999 set the entire field back decades.
If an astronaut dies from a predictable hematological complication during a high-profile mission, the political and public impact could paralyze space exploration programs for years.
The response, for now, is caution. Not to abandon the plans, but also not to proceed with the arrogance of thinking that the human body will adapt on its own.
The discoveries about the blood of astronauts are a clear reminder: microgravity is not just an inconvenience; it is an environment that attacks our organism at a cellular level. And until we know how to protect blood in space, talking about colonizing Mars is, at the very least, premature.
With information from the portal Xataka.
What do you think: should we continue investing in crewed missions to Mars even knowing that the bodies of astronauts suffer serious damage, or is it time to slow down until space medicine advances? Leave your opinion in the comments; this is one of the most important debates about the future of humanity outside Earth.
Seja o primeiro a reagir!